News
DGX
131.06
+1.70%
2.19
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
A blood test that analyzes levels of amyloid proteins in the brain could reduce the need for PET imaging in some patients with mild cognitive decline. The test could help reduce PET brain scan evaluations by about 40%. Quest Diagnostics will introduce the AD-Detect test to physicians in early 2022. The blood test is 91% sensitive for detecting Alzheimer's disease.
PR Newswire · 2d ago
Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test
NASDAQ · 3d ago
Weekly Report: what happened at DGX last week (0318-0322)?
Weekly Report · 3d ago
Quest Diagnostics Price Target Maintained With a $145.00/Share by Truist Securities
Dow Jones · 03/20 16:01
Key Takeaways From Quest Diagnostics Analyst Ratings
Quest Diagnostics is a leading provider of diagnostic testing, information, and services in the U.S. The company has an average 12-month price target of $145.0. 4 analysts have shared their insights on Quest Diagnostics in the past three months. The firm's revenue growth has been lower than the industry average. Quest Diagnostic's financial performance is impressive.
Benzinga · 03/20 16:00
Truist Securities Reiterates Hold on Quest Diagnostics, Maintains $145 Price Target
Benzinga · 03/20 15:52
Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)
Analyst David S Macdonald maintained a Hold rating on Quest Diagnostics (DGX) with a price target of $145.00. The company’s shares closed yesterday at $129.06. The analyst consensus on the stock is a Moderate Buy with an average of $142.27.
TipRanks · 03/20 11:15
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
Quest Diagnostics will report first quarter 2024 financial results on Tuesday, April 23, 2024. The company will hold its quarterly conference call to discuss the results. The earnings release and live webcast will be posted on www.QuestDiagnostics.com. Quest Diagnostics is a leader in diagnostic information services.
PR Newswire · 03/19 19:06
AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow
Riskier forms of corporate debt with higher yields are becoming increasingly popular. The Federal Reserve is expected to begin cutting rates later this year. Investors are looking to lock in high-yielding assets ahead of an expected decline in interest rates. Moody's approach to ratings has fueled the increased demand for corporate bonds.
Benzinga · 03/18 18:21
Weekly Report: what happened at DGX last week (0311-0315)?
Weekly Report · 03/18 09:11
Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Quest Diagnostics Incorporated (NYSE:DGX) has announced it will be increasing its dividend to $0.75 per share. The company's dividend is comfortably covered by earnings and is above the industry average. Quest Diagnostics has been growing its earnings per share at 7.3% a year over the past five years. The dividend yield of 2.4% makes the company a good investment for investors.
Simply Wall St · 03/15 19:58
Weekly Report: what happened at DGX last week (0304-0308)?
Weekly Report · 03/11 09:11
Why Is Encompass Health (EHC) Up 5.3% Since Last Earnings Report?
NASDAQ · 03/08 16:30
(DGX) - Analyzing Quest Diagnostics's Short Interest
Quest Diagnostics's short percent of float has fallen 13.05% since its last report. The company has 2.97 million shares sold short, which is 3.53% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 03/05 13:15
Weekly Report: what happened at DGX last week (0226-0301)?
Weekly Report · 03/04 09:11
Quest Diagnostics Inc: Statement of changes in beneficial ownership of securities
Press release · 03/01 23:08
FACTBOX-Germany builds up LNG import terminals
Germany builds up LNG import terminals to replace Russian pipeline gas. First vessel carrying liquefied gas for Germany's Baltic Sea terminal of Mukran arrives for a test operation. Germany is using floating storage and regasification terminals to help replace piped Russian gas supplies. Three other terminals are already operating in the North Sea.
Reuters · 02/28 17:18
Quest Diagnostics Inc: Statement of changes in beneficial ownership of securities
Press release · 02/27 23:05
Quest Diagnostics' (DGX) New Pact to Reduce Food Insecurity
NASDAQ · 02/27 17:19
Breaking Down Quest Diagnostics: 7 Analysts Share Their Views
Quest Diagnostics (NYSE:DGX) underwent analysis by 7 analysts in the last quarter. The company has an average price target of $146.71. Quest Diagnostics is a leading provider of diagnostic testing, information, and services in the U.S.
Benzinga · 02/26 18:01
More
Webull provides a variety of real-time DGX stock news. You can receive the latest news about Quest Diagnostics Inc through multiple platforms. This information may help you make smarter investment decisions.
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It provides diagnostic information services for infectious diseases, such as tuberculosis (e.g., T.SPOT.TB and Quantiferon offerings) and tick-borne disease (e.g., Accutix offering). Its comprehensive offerings in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (e.g. CARDIO IQ and Cleveland HeartLab offerings through its Cardiometabolic Center of Excellence), and in cancer diagnostics. Its Diagnostic Solutions business consists of its risk assessment services and healthcare information technology businesses. Its risk assessment service, ExamOne, is a provider of risk assessment services for the life insurance industry in North America.